Becker's Healthcare March 1, 2023
Noah Schwartz

Artificial intelligence-powered precision medicine company Tempus is partnering with pharmaceutical giant Pfizer on a project aiming to advance the use of AI and machine learning capabilities in oncology therapeutic discovery.

Through the partnership, Tempus will grant Pfizer access to its data library, diagnostic offerings and clinical trial matching program, according to a Feb. 28 Tempus news release.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma, Pharma / Biotech, Precision Medicine, Technology, Trends
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article